g , Left, percent of cell number from Slc33a1 -knockout KP cells expressing a vector control or SLC33A1 cDNA treated with DMSO or tunicamycin for 4 days under indicated concentrations
The development of safer and more economical hypoglycemic drugs has become the need of the hour urgent problem for researchers
Research and Development Despite these challenges, the benefits of GLP-1 receptor agonistssuch as improved blood sugar control and weight managementare substantial, and research continues to focus on improving these therapies: Improving Formulations: Ongoing research aims to develop new formulations that might reduce side effects or offer easier methods of administration
Both slow gastric emptying and can cause significant constipation
In: Nandula VK (ed) Glyphosate resistance in crops and weeds: history, development, and management
Over days or weeks, this reflex tension may accumulate into chronic neck discomfort that feels unrelated to the original nausea